USPTO serial 99502876
EZRA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, CATHERINE ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with EZRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY, US
New York, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew P. Hintz
Matthew P. Hintz Lowenstein Sandler LLPOne Lowenstein DriveRoseland, NJ 07068United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software featuring the use of artificial intelligence (AI) for interpreting MRI scans for the purposes of detecting cancer and other health risks; downloadable software in the nature of a mobile application for recording, analysis, storage, manipulation and organization of MRI results, health screening results, and genetic and molecular data; downloadable software in the nature of a mobile application for providing access to multiple databases that contain aggregated results of molecular biology testing and genotyping; downloadable publications in the nature of electronic reports, articles, bulletins, newsletters in the fields of cancer screening, health screening, genetic testing, genotyping technologies, genetic screening, phenotyping, molecular analytics, and ancestry | ACTIVE | — |
| 010 | Medical apparatus and instruments for use in medical diagnosis of and diagnostic testing for cancer and other health risks; instruments and articles generally used for the medical diagnosis of and diagnostic testing for cancer and other health risks | ACTIVE | — |
| 041 | Providing an online resource center, namely, online non-downloadable articles and academic papers in the fields of cancer screening tests, genetic testing and genotype technologies; providing a website featuring online non-downloadable publications in the nature of articles, journals, brochures, leaflets, guides and manuals in the fields of cancer screening tests, genetic testing and genotype technologies; providing online non-downloadable educational publications in the fields of cancer screening tests, genetic testing and genotype technologies. | ACTIVE | — |
| 042 | Medical research services, namely, providing scientific analysis and informational reports based upon results of laboratory testing for cancer detection and health screening purposes; Scientific research services, namely, providing scientific analysis and informational reports based upon results of laboratory testing in the field of genetics; providing temporary use of online non-downloadable software featuring the use of artificial intelligence (AI) for interpreting MRI scans for the purposes of detecting cancer and other health risks; providing temporary use of online non-downloadable software for recording, analysis, storage, manipulation, and organization of MRI results, health screening results, and genetic and molecular data; providing online computer databases featuring scientific and medical research information based on aggregated results of genotyping; application service provider (ASP) featuring software for providing access to multiple databases that contain aggregated results of genotyping; application service provider (ASP) featuring software for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, and ancestry; scientific research in the fields of genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, and ancestry | ACTIVE | — |
| 044 | Health care services for treating prostate cancer and other cancers; health care services, namely, disease management programs; health screening services in the field of prostate cancer, and other cancers; counseling services in the fields of health, nutrition and lifestyle wellness; providing health care information by individual and group counseling; wellness and health-related consulting services; health care services, namely, wellness programs; medical imaging services; human healthcare services namely, treatment of prostate cancer and other cancers; medical services for the diagnosis of conditions of the human body, namely, prostate cancer, breast cancer, speech disorders, and infertility. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EZRA AI, Inc.
- Other trademarks owned by EZRA AI, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EZRA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 3, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 28, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 2, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 2, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 2, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 2, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 29, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 29, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 25, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 25, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 18, 2025 | NWAP | NEW APPLICATION ENTERED | — |